Cashu | Summary

DJI

+0.45%

SPX

+0.49%

IXIC

+0.80%

FTSE

+0.52%

N225

+0.60%

AXJO

+0.90%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

HomeWatchlistNewsSignalsPicks

DJI

+0.45%

SPX

+0.49%

IXIC

+0.80%

FTSE

+0.52%

N225

+0.60%

AXJO

+0.90%

HomeWatchlistNewsSignalsPicks

Join our newsletter to keep up to date with us!

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Instagram YouTube

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap

25.03M

Dividend Yield

0.00%

P/E Ratio

-2.57

EPS

-0.72

Revenue

Avg. Volume

72.67K

About

What does NNVC do?

NanoViricides, based in Shelton, Connecticut, develops nanomedicine drugs targeting enveloped viruses, with lead candidates NV-CoV-2 for COVID-19 and NV-HHV-1 for Shingles. The company went public on August 12, 2004.

Sector

💻 Health Care

IPO

August 12, 2024

CEO

Dr. Anil R. Diwan

Employees

Headquarters

Connecticut, USA

Website

http://www.nanoviricides.com

Recently from Cashu

Cashu

Why NanoViricides (NNVC) Could Be a $6 Stock — And Why Investors Are Starting to Notice

2 months ago

Cashu

The Tiny Biotech Aiming to Disrupt the $80 Billion Antiviral Market: Why NanoViricides (NNVC) Deserves a Closer Look

2 months ago

Cashu

Could This Tiny Biotech Be the Key to Stopping a Measles Comeback?

3 months ago

Stocks

Health Care

nnvc

NanoViricides

NNVC

+0.07 (+4.37%)

1.67

USD

At close at Jul 17, 17:37 UTC